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Abstract
The fabrication of bioactive scaffolds able tomimic the in vivo cellularmicroenvironment is a
challenge for regenerativemedicine. The creation of sites for the selective binding of specific
endogenous proteins represents an attractive strategy to fabricate scaffolds able to elicit specific cell
response. Here, electrospinning (ESP) and soft-molecular imprinting (soft-MI) techniqueswere
combined to fabricate a soft-molecular imprinted electrospun bioactive scaffold (SMIES) for tissue
regeneration. Scaffolds functionalized using different proteins and growth factors (GFs) arranged onto
the surface were designed, fabricated and validatedwith different polyesters, demonstrating the
versatility of the developed approach. The scaffolds bound selectively each of the different proteins
used, indicating that the soft-MImethod allowed fabricating high affinity binding sites on ESPfibers
compared to non-imprinted ones. The imprinting of ESPfibers with several GFs resulted in a
significant effect on cell behavior. FGF-2 imprinted SMIES promoted cell proliferation andmetabolic
activity. BMP-2 andTGF-β3 imprinted SMIES promoted cellular differentiation. These scaffolds hold
the potential to be used in a cell-free approach to steer endogenous tissue regeneration in several
regenerativemedicine applications.
1. Introduction
In regenerative medicine, scaffolds should act as
biocompatible and biodegradable substrates to pro-
mote cell attachment, migration, proliferation and
ECM deposition. Furthermore, scaffolds should have
the proper surface chemistry and topography to
sustain tissue development [1]. Synthetic polymers are
commonly used for the fabrication of scaffolds due to
their high processing flexibility, controllable degrada-
tion rates and mechanical properties. However, they
lack different biological features needed for tissue
regeneration, such as natural cell binding sites. Conse-
quently, cell adhesion on scaffolds made by synthetic
polymers occurs via ECM molecules unspecifically
adsorbed on their surfaces [1, 2]. In order to guide cell
behavior and tissue formation, significant efforts have
been made to fabricate functionalized scaffolds to
promote cell/material interactions. These interactions
require biomolecular recognition of materials by cells,
which can be manipulated by the fabrication para-
meters of the biomaterials, such as modifying the bulk
structure or surface with bioactive molecules [1, 3]. In
the former strategy, biomolecules are incorporated
into the biomaterial and the recognition sites are
present on the bulk structure. In the latter strategy,
biomolecules are immobilized on the surface of the
biomaterial and the recognition sites are only on the
surface [3, 4]. However, bulk modification is not an
efficient method to incorporate biomolecules because
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cell–material interactions take place on scaffold sur-
faces and the biomolecules encapsulated inside the
scaffolds are not able to interact with cells [1]. For this
reason, surface modification is preferred to fabricate
bioactive scaffolds [1].
Currently, several techniques have been developed
to modify the surface of scaffolds including physical
coating and blending [5], plasma treatment [6, 7],
graft polymerization, andwet chemicalmethods [5]. Lim-
itations include poor controllability (coating), alteration
of the bulk properties (blending, and wet chemical
methods), limited shelf-life (plasma treatment). Mole-
cular imprinting (MI) technology represents a novel
possibility to obtain molecular recognition sites in
polymer structures. MI is a synthetic approach to design
robustmolecular recognitionmaterials able tomimicnat-
ural recognition entities, such as antibodies and biological
receptors [8]. Template molecules, crosslinked to a poly-
mer and subsequently removed, impart molecular mem-
ory into the biomaterial, which selectively binds to the
imprinted templatemolecules.
MI polymers (MIPs) have been used for specific
recognition of different molecules, such as drugs and
peptides. However, protein imprinting had a limited
success due to their large molecular size [9]. Different
studies used conventional methacrylate chemistries to
prepare protein MIPs [10]. The major limitation of
this approach is related to the use of solvents. Further-
more, proteins are insoluble in non-aqueous media
and their conformation is strongly modified, influen-
cing in this way the efficiency of the MIPs [11].
Imprintable hydrogels represent a suitable alternative
based on protein encapsulation to fabricate delivery
agents, but different studies demonstrated that it is
possible only for small molecules [12]. 3D sol-gel pro-
tein imprinting represents another alternative for the
fabrication of MI structures able to recognize specific
template molecules. Sol-gel can interact with a variety
of proteins for their encapsulation, because a sol-gel
reaction is suitable for imprinting proteins due to the
mild polymerization conditions and water compat-
ibility [12]. However, the bulk imprinting of proteins
is limited by the sol-gel dense structure and the
requirements of grinding to expose binding sites [11].
A novel method of protein imprinting was demon-
strated by Umeno et al who used a polymer coated
DNA strand for protein recognition, but the practical
use of this method is limited by the high complex-
ity [13].
These methods for protein imprinting demon-
strated the potential of MI technologies for different
applications such as specific protein entrapment and
separation [11]. However, their use in the regenerative
medicine field is still partially unknown due to the
restrictions related to the biocompatibility require-
ments and to the structural andmechanical properties
of the scaffolds [14].
Rosellini et al proposed a bioactive scaffold with
fibronectin recognition nanosites based on MI [15].
The imprinted particles showed good performance in
terms of recognition capacity, quantitative rebinding
and selectivity, and were used to functionalize synth-
etic polymeric films by deposition on their surface.
The deposition of the imprinted particles did not alter
their specific recognition and rebinding behavior and
the functionalized materials promoted cell adhesion
and proliferation. Nevertheless, a possible application
in regenerative medicine is far to be achieved
because the structural and mechanical properties of
these structures are strongly different from tissues.
Vozzi et al proposed the Soft-MI technique, which
integrates MI and soft lithography, to enhance specific
cell response due to the presence of highly specific
recognition sites onwell-definedmicrostructures [16].
PMMA scaffolds with a specific microstructure were
fabricated via casting and imprinted with different
proteins. However, this method did not mimic the
fibrous architecture of soft tissues.
In regenerative medicine, the possibility to tailor
the scaffold structural and mechanical properties and
to functionalize its surface with bioactive agents repre-
sents a fundamental option to mimic the hierarchical
aligned structure of the native tissues. In this sense,
patterned electrospun fibers represent a suitable
technique to replicate the ligament micro- and nano
structures [17].
Chronackis et al developed a simple method to
create recognition sites on electrospun fibers [18]. A
solution of poly(ethylene terephthalate) (PET) and
polyallylamine in the presence of an herbicide as a
template molecule, 2,4-dichlorophenoxyacetic acid
(2,4-D), was used to fabricate the imprinted electro-
spun nanofibers. When the template was removed by
solvent extraction, imprinted binding sites were left in
the nanofibermaterials that were capable of selectively
rebinding the target molecule. The rebound capacity
in the case of imprint nanofibers was 5 times higher
than the one showed by non-imprinted nanofibers.
Here, we combine soft-MI and ESP, which we
denoted as ‘SMIES’, to fabricate novel bioactive scaf-
folds based on polylactic-co-glycolic acid (PLGA).
These scaffolds could find applications for several
stromal tissues, such as ligament [17]. We then fabri-
cated scaffolds based on poly(ethylene oxide ter-
ephthalate)/poly (butylene terephthalate) (PEOT/
PBT) and poly-L-D-lactic acid (PLDLA), which also
showed the capability to selectively bind a specific
template molecule (described in the supplementary
information available online at stacks.iop.org/BF/10/
045005/mmedia).
Together, these studies demonstrate that our novel
SMIES technique can be used to fabricate bioactive
scaffolds that mimic an in vivo cellular microenviron-
ment, with diverse potential for broad regenerative
medicine applications.
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2. Experimental section
2.1. SMIES fabrication
The fabrication method of SMIES consists of three
main steps: fabrication and functionalization of poly-
dimethylsiloxane (PDMS) molds, and fabrication of
the scaffolds by ESP (figure 1).
2.1.1. Fabrication of the PDMSmold
The PDMS mold fabrication and functionalization
followed the protocol described by Bhatia et al [19]
and Vozzi et al [16], respectively. The negative photo-
resist NANOTM SU-8 50 (MicroChem, Newton, MA)
was spin-coated on the silicon wafer, pre-baked to
remove the solvent, aligned with a mask aligner
(NL-CLR-EV620 Maskaligner) and exposed to UV
rays in contact mode. Subsequently, a post-exposure
bake to complete the polymerization of the photoresist
and a development phase to remove unexposed
material were performed. The mask was designed
using the software CleWin 4.0 and printed on a
transparency using a commercial Linotronic-Hercules
3300-dpi, high-resolution line printer. The mask was
divided into seven structures and a pattern composed
by lines with a length of 100 μm and a line distance of
50 μm was chosen. The PDMS mold was prepared
using a commercial product (Sylgard 184 kit, Dow
Corning, MI) with a 10:1 (w/w) ratio. The solution
was centrifuged for 1 min at 300 rpm, casted onto the
master, degassed, and finally cured in an oven for 4 h
at 70 °C. Finally, themaster was separated fromPDMS
and the mold was then washed with 70% ethanol
(Sigma Aldrich, The Netherlands), and subsequently
with deionizedMilliQwater to eliminate impurities.
2.1.2. Functionalization of the PDMSmold
The functionalization of the PDMSmold was performed
using the method described by Vozzi et al [16]. First, the
mold was washed with acetone (Sigma Aldrich, The
Netherlands). After evaporation, it was immersed in
Piranha Solution (H2SO4/H2O2, 3:1 v/v) for 30 s to
reduce the hydrophobicity of its surface, and subse-
quentlywashedwith deionizedwater. After themodifica-
tion of its surface wettability, the PDMS mold was
derivatised with a 1% v/v solution of (3-Aminopropyl)-
trimethoxysilane (APTS) (purity97%, Sigma Aldrich,
The Netherlands) in Toluene anhydrous 99.8% (Sigma
Aldrich, TheNetherlands). Toluene was used as a solvent
because of its capacity to create amonomolecular layer of
silanes on the PDMS surface. Themold was immersed in
the APTS solution for 1 h in order to introduce amino
groups on its surface to promote protein binding.
Subsequently, the mold was washed three times with
toluene to remove any excess of silane, and dried in an
Figure 1. SMIES fabrication process (A): (a) soft lithography process for the fabrication of PDMSmolds; (b) functionalization of
PDMSmolds by chemical treatment (piranha solution, derivatizationwithAPTES, activationwith EDC-NHS solution and incubation
with a template protein); (c)ESP of the polymer solution on top of the functionalized PDMSmolds; (d) removal of the electrospun
scaffolds from themolds to obtain the imprinted scaffolds (i.e. SMIES).Morphologic characterization of SMIES:microtopography
shows uniformnanofibers and stripedmicrostructure (inset, scale bar: 100 μm) (B) and the control (not imprinted scaffolds) that
shows similar uniformnanofibers and stripedmicrostructure (inset, scale bar: 100 μm) (C); surface roughness (Rq, at scan size of
1 um) (D) andwettability (determined by contact angle)were similar for SMIES and non-imprinted PLGA scaffolds (control) (E).
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oven at 40 °C for 1 h to ensure the complete evaporation
of the solvent.
The activation of the functional groups of the sila-
nized surface was promoted by dipping the mold for
1 h into an aqueous solution (pH=6.4) of 2 mM
hydroxysuccinimide (NHS) (purity98.0%, Sigma
Aldrich, The Netherlands), and 5 mM dimethylami-
nopropyl-ethyl-carbodiimide (EDC) (purity=97%,
Aldrich, The Netherlands). This step allowed the reac-
tion between the nucleophilic groups present on the
PDMS mold and the carboxylic groups of the protein
and vice versa, the carboxylic groups present on the
PDMS mold and nucleophilic groups of the protein
[20]. Then, themold was washed with deionized water
to remove any excess reagent.
The PDMS mold was immersed in a solution of
the template protein at 4 °C in the dark. After 24 h, the
mold was washed with deionized water to remove any
excess protein. FITC-albumin and TRITC-lectin
(Sigma Aldrich, The Netherlands) were initially
used as template model molecules for the MI of elec-
trospun scaffolds, for evaluating the binding activity.
Deionized water solutions of FITC-albumin and
TRITC-lectin at concentrations of 1 μg ml−1 in deio-
nizedwaterwere prepared.
After the demonstration of the proof-of-concept
with fluorescent molecules, the PDMS mold was
functionalized with the growth factors (GFs) FGF-2
(Neuromics), TGF-β3 or BMP-2 (R&D Systems), for
application in stromal (e.g. ligament) tissue engineer-
ing. Deionized water solutions (one for each GFs) at a
concentration of 10 ng ml−1 were prepared.
2.1.3. Electrospinning process
The functionalized PDMS mold was used as a target
for the ESP jet. SMIES were fabricated using a 4%w/v
PLGA (Boehringer-Ingelheim) solution in 1,1,1,3,3,3-
hexafluoro-2-propanol (HFIP) (Sigma Aldrich, The
Netherlands).
ESP was performed in an environmental chamber
with a controlled temperature of 25 °C and a relative
humidity of 30%. The polymer solution was loaded
into a 5 ml syringe (BD Biosciences) and pumped
using a syringe pump (KDS-100-CE, KD Scientific)
through a Teflon tube connected to a stainless
steel needle (0.5 mm inner diameter, 0.8 mm outer
diameter). The needle was mounted in a 30×20 cm
upper parallel plate and centered on a custom made
collector composed by twoflat aligned electrodes.
The functionalized PDMS mold was positioned
under the ESP jet, on top of the two aligned electrodes,
and the ESP fibers fabricated at a flow rate of 1 ml h−1,
a voltage of 20 kV and a needle-collector distance of
20 cm. The ESP fiber density was determined as the
time frame used during fabrication, which was set
to 4 h.
2.2. Scaffold characterization
Details on morphological and mechanical character-
ization are given in supporting information, as not
specifically developed for SMIES. Investigations
include scanning electron microscopy, porosity, per-
meability, surface wettability, surface roughness, uni-
axial tensile and stress relaxation tests and their
explanation using the modified quasi linear viscoelas-
ticitymodel (mQLV) [21].
2.3. Rebinding ability and selective recognition
analysis
In order to evaluate the rebinding ability and the
selectivity for the template molecule (FITC-albumin or
TRICT-lectin), the imprinted scaffolds (n=3) were
dipped in three different aqueous solutions: FITC-
albumin (1μgml−1), TRITC-lectin (1 μgml−1) and
bothproteins (1:1, 1 μgml−1). TheobtainedSMIESwere
washed 3 times with water and analyzed by fluorescence
microscope (non-inverted NIKON E600) to ensure that
no weakly bound protein on the PDMS was transferred
to them. A Texas Red filter (excitation wavelength
542–576 nm, emission wavelength 600–675 nm) and a
FITCfilter (excitationwavelength488–495 nm, emission
wavelength 519 nm) were used to distinguish lectin and
albumin, respectively. Pictures were taken with a Nikon
DS-Fi1c camera equippedwithNIS-Element software.
2.4. GF imprinting quantification
The quantification of the rebound BMP-2 and
TGF-β3 GFs was performed through an enzyme-
linked immunosorbent assay (ELISA, R&D systems).
Briefly, after the imprinting procedure, the super-
natant containing the soluble GF was collected to
quantify the amount of unlinked protein. The GF left
in the supernatant from a control scaffold (not
imprinted) was also quantified to determine non-
specific protein adsorption. The imprinting efficiency
ratio was defined as the ratio between the signal of the
target molecule obtained with the imprinted scaffold
and the signal of the target molecule obtained with a
non-imprinted scaffold, under the same conditions
[22]. BMP-2 and TGF-β3 were quantified using an
ELISA assay according to the manufacturer’s instruc-
tions (DY355-05 and DY243, respectively). The plate
was gently mixed before reading the absorbance at
450 nm using a Multiscan Go (Thermo Scientific,
USA). Triplicates were used for each condition.
2.5. Cell expansion and culture conditions
Different biological investigations were performed to
validate the imprinted PLGA SMIES. The scaffolds for
cell culture experiments were produced as before,
punched into 22 mm disks to fit inside a sterile, non-
treated 12-well plate (NUNC). Viton® polymer rings
(Eriks b.v., The Netherlands), with an outer diameter
of 22 mm and an inner diameter of 19.6 mm, were
sterilized in 70% ethanol and inserted into the wells to
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hold the scaffolds to the bottom. The rings also served
to confine seeded cells to the scaffold only. Subse-
quently, the scaffolds were sterilized in 70% ethanol
for 15 min, washed twice in PBS solution (Gibco-BRL)
for 5 min, and incubated in proliferation medium
overnight to pre-wet the scaffold and promote protein
adsorption. Three different cell types were used,
according to the imprinted GF: human mesenchymal
stromal cells (hMSCs) for FGF-2, mink lung epithelial
cells (MLECs) for TGF-β, and mouse myoblast cells
for BMP-2. Details of culture conditions of each cell
type is given in the supplementary information.
2.6. Cell imaging—scanning electronmicroscopy
A Philips XL ESEM-FEG was used to observe cell
attachment and distribution after 7 days of culture.
Briefly, SMIES were washed twice with PBS and fixed
in 10% formalin for 15 min. The samples were, then,
dehydrated in sequential ethanol series (50%, 60%,
70%, 80%, 90%, 96% and 100%), 15 min for each
concentration. Scaffolds were immersed in hexam-
ethyldisilazane (Sigma Aldrich, The Netherlands) for
the final dehydration step. Hexamethyldisilazane was
left to evaporate overnight. Finally, samples were gold
sputter-coated (Cressington Sputter Coater 108 auto)
prior to SEManalysis. An acceleration voltage of 10 kV
and a working distance of 10 mmwere used to acquire
images.
2.7. Cell imaging—fluorescencemicroscopy
Cell morphology and distribution was evaluated by
fluorescence microscopy after 1, 3 and 7 days of
culture. After rinsing twice with PBS, scaffolds were
fixed in 10% formalin for 15 min. Cell membranes
were permeabilised with 0.25% (v/v) Triton X-100
(Sigma Aldrich) in PBS for 5 min, followed by 3 times
rinsing in PBS for 5 min each. Non-specific binding
was blocked using 1% (w/v) BSA in PBS. Nuclei were
labeled by incubating the samples with 100 ng ml−1 of
4’,6’ Diamidin-2’-phenylindoldihydrochlorid (DAPI,
Sigma, Munich, Germany) in PBS for 20 min. After
further washing the sample 3 times with PBS, actin
filaments were stained with 200 ng ml−1 of Phalloidin
(Alexa Fluor 594 Phalloidin, Invitrogen) for 1 h to
visualize the cytoskeleton. Samples were again rinsed 3
times, stored in the dark, and subsequently analyzed
on a fluorescence microscope (Nikon Eclipse E600).
A BFP filter (excitation wavelength 379–401 nm,
emission wavelength 438–485) was used for DAPI
staining and a Texas Red filter (excitation wavelength
542–576 nm, emission wavelength 600–675 nm) for
phallodin. Pictures were taken with a Nikon DS-Fi1c
camera equippedwithNIS-Element software.
2.8. Biochemical investigations
2.8.1. Presto blue assay
Presto blue assay (Life technology, The Netherlands)
was conducted to assess the influence of FGF-2
imprinted scaffolds onmetabolic activity after 1, 3 and
7 days of culture. Briefly, a cell permeable resazurin-
based solution was diluted 10 times in the same type of
medium in which cells were cultured, according to the
manufacturer’s instructions: 1.5 ml of basic medium
supplemented with Presto blue reagent was placed in
eachwell and incubated for 2 h in the dark at 37 °C in a
humidified atmosphere with 5% CO2. Living cells
modified the reagent, which turned red in color.
100 μl of medium from each sample was moved in a
clear-bottom 96-well black plate. The color change
was detected using a spectrophotometer LS50B (Victor
3, Perkin Elmer) according to the manufacturer’s
instructions. The experiments were performed in
triplicate.
2.8.2. DNAassay
The amount of DNA was calculated with CyQuant
DNA assay kit (Molecular Probes, Invitrogen) to
quantify the cell number after 7 days of culture,
according to the manufacturer’s instructions. Briefly,
the FGF-2—imprinted scaffolds were cut in order to
improve the lysis efficiency. Samples were stored at
−30 °C and freeze-thawed 5 times. Afterwards, the
constructs were digested for 16 h at 56 °C with
1 mgml−1 proteinase K (Sigma Aldrich) in Tris/
EDTA buffer (pH 7.6) composed of 18.5 μg ml−1 of
iodoacetamine (Sigma Aldrich) and 1 μg ml−1 Pepsta-
tinA (SigmaAldrich). To avoid the interference caused
by the binding of the dye to the RNA, 100 μl of the
sample were incubated for 1 h at room temperature
with 100 μl of lysis buffer provided by the kit (Comp-
onent B diluted in 180 mM NaCl, 1 mM EDTA in
distilled water in the ratio 1:20), in which RNAse
enzyme was diluted 1000 times. Quantification of the
total DNAwas accomplished using a green fluorescent
dye provided by the kit (excitation 480 nm, emission
520 nm). Fluorescence was detected at 480 nm using a
spectrophotometer LS50B (Victor 3, Perkin Elmer),
and DNA concentrations were calculated from a λ
DNA standard curve.
2.8.3. Luciferase assay
To evaluate the activation of TGF-β3 and BMP-2
signaling pathway inducedby the imprinted scaffolds, the
reporter cell lines described above were used [23]. In
particular, MLECs were used to evaluate TGF-β3 and
C2C12 cells were used to monitor the BMP-2 pathway.
The scaffolds were imprinted with 10 ngml−1 of the
respectiveGF.As controls, non-imprinted and imprinted
scaffolds in which the media was supplemented with
10μM/well of a GF inhibitor were used. Noggin (Sigma
Aldrich, The Netherlands) was used as BMP-2 inhibitor
5
Biofabrication 10 (2018) 045005 GCriscenti et al
andSB431542hydrate (SigmaAldrich, TheNetherlands)
as TGF-β3 inhibitor. After seeding, cells were cultured in
DMEM (Gibco) supplemented with FBS (10% (w/v),
Lonza), penicillin (100Uml−1,Gibco), and streptomycin
(100μgml−1, Gibco). After 24 h, the medium was
exchanged with an equal one in which the FBS was not
added.
After 3 days of culture, the luciferase assay was per-
formed according to the manufacturer’s instructions
(PROMEGA Corporation, USA). Briefly, samples
were gently washed three times with PBS. The reporter
lysis buffer was diluted (1:5), and 1 ml was added to
both samples and controls. Subsequently, the plate
was covered with aluminum foil and stored at−80 °C.
To perform the analysis, 100 μl of lysate and luciferase
assay buffer were transferred to a white, 96-well plate
and analyzed using spectrophotometer LS50B (Victor
3, Perkin Elmer) according to the manufacturer’s
instructions. Luciferase activity, reported as relative
light units, was normalized for theDNA content.
2.9. Statistical analysis
All data are expressed as mean±standard deviation
(SD). Biochemical assays were performed on triplicate
biological samples. A one-way statistical analysis of
variance (ANOVA) with a significance level of p<0.05
was used to determine differences between three groups
present in the luciferase assay. Tukey’smultiple compar-
isons test was used to perform post hoc analysis. A t-test
was performed with a significance level of p<0.05 to
compare results obtained in the other experiments.
Statistical significance between the control group and the
experimental groups is indicated, with the following
designations: *p-value<0.05, **p-value<0.01, and
***p-value<0.001.
3. Results and discussion
We fabricated PLGA-based SMIES imprinted with
FITC-albumin, TRITC-lectin, FGF-2, TGF-β3 or
BMP-2. The scaffolds had an interconnected pore
network, composed of uniform nanofibers with mean
diameters of 571±70 nm, corresponding to a porosity
of 94.2±2.4%. Scaffolds thickness was 150–200 μm,
approximately. Their microstructure accurately con-
formed to the striped pattern of the PDMS mold. The
theoretical line width was set to 100 μm (equal to the
spacing on PDMSmold) and the experimental one was
measured as 104±4 μm. The theoretical distance
between two lines was set to 50 μm and the exper-
imental valuewasmeasured as 65±9 μm.
The SMIES fabricationmethod did not change the
morphological properties of the PLGA scaffolds com-
pared to non-imprinted ESP fabrication. The surface
roughness (Rq), a measurement for cell and protein
attachment, was 160.2±32.4 nm for the imprinted
PLGA scaffolds and 170.4±50.8 nm for the non-
imprinted ones (figure 1(D)). The contact angle,
measured to assess the wettability of the scaffold sur-
face,
was 130.6±10.1° for the imprinted PLGA scaffolds
and 127.3±11.1° for the non-imprinted ones
(figure 1(E)), with no statistical differences between
the two groups. The scaffolds presented a similar per-
meability [L m−2 h−1 bar−1]: 38.9±1.73 for the
imprinted and 38.6±1.81 for the non-imprinted,
and a sieving coefficient (SC) of >0.96 for BSA
(66 kDa) indicating that large proteins permeated
freely through the scaffolds.
The similarity of the bulk properties of imprinted
and non-imprinted scaffolds was further confirmed by
mechanical tests (see supplementary information): no
statistically different elastic and viscoelastic properties,
including Youngmodulus (87.50±21.10 MPa versus
90.20±23.30 MPa) and relaxations times, were
observed. Comparablemechanical properties between
the native tissue and the synthetic substitute can pro-
mote adequate mechanical stimuli that, together with
other factors, can influence cell growth and differ-
entiation. In this case, the imprinted PLGA scaffold
showed mechanical and viscoelastic properties that
matched the ones of native soft tissues [24]. In part-
icular, the mQLV parameters obtained for the PLGA
scaffold resulted in a similar range with the ones of the
native ligament soft tissue [21].
With respect to the not-imprinted counterpart,
the SMIES demonstrated affinity and selectivity for
their template molecule over the other fluorescent
protein competitor (figure 2). The FITC-albumin-
imprinted PLGA SMIES showed high protein absorp-
tion in a solution of FITC-albumin (figure 2(A)), but
minimal adsorption in a solution of TRITC-lectin
(figure 2(B)).When both albumin and lectin were pre-
sent (1:1) in solution, the albumin-imprinted SMIES
bound only albumin (figures 2(C) and (D)). Analo-
gous results were obtained with the TRITC-lectin—
imprinted SMIES. Non-imprinted PLGA scaffolds
boundneither lectin nor albumin (figures 2(I)–(N)).
The quantity of imprinted GFs on the SMIES can
be evaluated through an indirect measurement with
ELISA tests. Results showed that BMP-2—imprinted
scaffolds were able to bind significantly more BMP-2
compared to unspecific binding observed on non-
imprinted scaffolds (12.4%, efficiency ratio=1.18,
p-value<0.01; figure 2(O); the efficiency ratio is
defined in materials and methods). Similarly, TGF-β3
—imprinted scaffolds bound 33% more TGF-β3
(efficiency ratio=1.62) compared to non-imprinted
controls (p-value<0.001, figure 2(P)). The relatively
high unspecific absorption of the two GFs is likely due
to the high available surface typical of electrospun
scaffolds. Further specificity could be achieved
through increasing the density of the MI sites in the
PDMS templatingmold.
To evaluate the SMIES’ ability to sustain cell pro-
liferation, hMSCs were cultured on the scaffolds and
cell morphology and distribution were evaluated after
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1, 3 and 7 days (figures 3(A)–(C)). hMSCs were homo-
geneously distributed at day 1 on the scaffold surface
and started to align along the microstructure at day 3.
Cells were well spread and in part aligned along the
microtopographies at day 7. SEM analysis after 7 days
of culture also revealed a homogenous distribution of
hMSCs on the entire scaffolds and their partial align-
ment along themicrotopographies (figures 3(D)–(G)).
FGF-2 imprinted scaffolds were tested for their
ability to promote cell proliferation analyzing cell
seeding efficiency (CSE), metabolic activity and cell
number after 7 days. The initial cell seeding procedure
is a critical step in a TE process. Cell seeding efficiency
analysis was performed to exclude the possibility
that subsequent changes in proliferation between the
FGF-2 imprinted scaffolds and the controls could be
Figure 2. SMIES (A) imprintedwith FITC-albumin dipped in FITC-albumin; (B) imprintedwith FITC-albumin dipped in TRITC-
lectin; (C), (D) imprintedwith FITC-albumin dipped in both proteins; (E) imprintedwith TRITC-lectin dipped in FITC-albumin; (F)
imprintedwith TRITC-lectin dipped in TRITC-lectin; (G), (H) imprintedwith TRITC-lectin dipped in both protein; (I)un-imprinted
PLGA scaffold dipped in FITC-albumin; (L) control (non-imprinted PLGA scaffold) dipped in TRITC-lectin; (M), (N) control dipped
in both proteins. Fluorescencemicroscopy of SMIES and control shows selective binding to the respective templatedmolecules.
SMIESwere imprintedwith either FITC-albumin (top row) or TRICT-lectin (middle row), then dipped into solutions containing
albumin (first column), lectin (second column) or both proteins (1:1, two right columns) before analysis. Controls showedno binding
to either protein (bottom row). Scale bar: 100 μm.Quantification of imprintedGFs on SMIES compared to controls (O-P **
p-value<0.01, *** p-value<0.001).
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due to differences in the initial seeding. CSE was eval-
uated after 24 h: for SMIES it was 29.3±7.9% and no
statistical difference between the SMIES and the con-
trols was found (figure 3(H)).
The metabolic activity after 1, 3 and 7 days was
assessed with Presto blue assay. The FGF-2 imprinted
scaffold showed a statistically significant increase of
themetabolic activity for each time point compared to
the control (figure 3(I)). The DNA quantification after
7 days of cell culture confirmed the trend presented in
the metabolic activity analysis, showing a statistically
significant increase of proliferation on FGF-2 imprin-
ted scaffolds compared to the control (figure 3(L)).
These results suggest that FGF-2 present onto the
SMIES was capable of eliciting the expected pro-mito-
genic effect on hMSCs ultimately leading to a higher
number of cells compared to the control.
In order to evaluate the effective presence and
bioactivity of the imprinted BMP-2 and TGF-β3, a
luciferase assay was performed with specific reporter
cell lines. In this test, an increase in luciferase activity
corresponds to an increase onBMP-2 andTGF-β3 sig-
naling. Luciferase activity was normalized for theDNA
content to correct for the total cell number in the scaf-
folds. As showed in figures 3(M), (N), SMIES pre-
sented a higher luciferase activity compared to the
controls and to the SMIEs with the addition of specific
inhibitors of BMP-2 and TGF-β3, suggesting that the
imprinted scaffolds were able to bind and present the
respectiveGFs to the reporter cell line.
The imprinting of ESP fibers with several GFs resul-
ted in a significant effect on cell behavior. In particular,
FGF-2 promoted cell proliferation and FGF-2 SMIES
showed a statistically higher metabolic activity over time
and a higher number of cells after 7 days. BMP-2 and
TGF-β3 SMIEs showed a statistically higher luciferase
signal that demonstrated the presence and the bioactivity
of GFs binding domains. Further studies should aim at
elucidating whether this method is also applicable for
thicker electrospun scaffolds, where cell migration
becomes notoriously more challenging. In addition, the
efficacy of these imprinted scaffolds should be further
evaluated in animals compared to non-imprinted scaf-
folds to confirm thepromising results obtained in vitro.
4. Conclusion
The presented research shows for the first time the
possibility to imprint nanofibers to create bioactive ESP
scaffolds for regenerativemedicine applications. Future
investigations will focus on the optimization of the
imprinting procedure to improve the efficiency of the
Figure 3. hMSCs proliferate and align on FGF-2–SMIES, as visualized by fluorescencemicroscopy (A)–(C) and SEM (D)–(G) after day
1 (A), day 3 (B), and day 7 (C)–(G) of culture. Scale bars represent 200 μm (D), 100 μm (A)–(C), (E), 50 μm (F), and 20 μm (G); cell
seeding efficiency of FGF-2 SMIES (H)metabolic activity of FGF-2 SMIES after 1, 3 and 7 days (I) and proliferation analysis of FGF-2
SMIES after 7 days of culture (L); luciferase activitymeasured using a TGF reporter cell line for TGF-β3 SMIES (M) andBMP reporter
cell line for BMP-2 (N) SMIES.
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process, on imprinted GF release analysis over time,
and on further characterizationofGFs’ influence on cell
differentiation. Moreover, the possibility to imprint a
‘mimic analog peptide’ able to replicate the ‘imprinting
site’ of specific GFs represents a fascinating improve-
ment in order to reduce the manufacturing costs and
fabricate a completely synthetic imprinted scaffold able
to selectively bind a targeted protein. In addition, an
innovative approach could be represented by ‘direct cell
imprinting’, in which cells can be used as template
structure to imprint ESPfibers.
In conclusion, the integration of ESP and soft-MI
represents a powerful and promising technique for the
fabrication of scaffolds for regenerative medicine
applications, because it allows us to get one step closer
tomimic the structuralmicroenvironment of tissues.
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